𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients

✍ Scribed by Eva Angenete; Marcus Langenskiöld; Ingrid Palmgren; Peter Falk; Tom Öresland; Marie-Louise Ivarsson

Book ID
106059405
Publisher
Springer
Year
2007
Tongue
English
Weight
170 KB
Volume
22
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms in the transforming growth
Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression
✍ Asta Försti; Xuchen Li; Kerstin Wagner; Björn Tavelin; Kerstin Enquist; Richard 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract Transforming growth factor β1 (TGFB1) acts as a growth inhibitor of normal colonic epithelial cells, however, as a tumor promoter of colorectal cancer (CRC) cells. To explore the association between genetic polymorphisms in the TGFB1 pathway and CRC susceptibility and clinical outcome,

Heparin-binding epidermal growth factor-
Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome
✍ Christopher Kramer; Kai Klasmeyer; Hans Bojar; Wolfgang A. Schulz; Rolf Ackerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

## Abstract ## BACKGROUND. Cleavage of membrane‐anchored heparin‐binding epidermal growth factor‐like growth factor (proHB‐EGF) yields a soluble HB‐EGF isoform (sHB‐EGF), which is an activating epidermal growth factor receptor (EGFR) ligand and a C‐terminal fragment HB‐EGF‐C acting directly in the